Concordance of two polymerase chain reaction–based blood group genotyping platforms for patients with sickle cell disease Cover

.blurhash-client-img { display: none !important; }

Concordance of two polymerase chain reaction–based blood group genotyping platforms for patients with sickle cell disease

Immunohematology

Volume 36 (2020): Issue 4 (December 2020)

By: C.A. Sheppard, N.L. Bolen, G. Meny, M. Kalvelage and G. Ochoa-Garay

Paid access

|Jan 2020

Authors

C.A. Sheppard

Gold Standard Laboratory Consulting Group, LLC, and Department of Pathology, University of Virginia, Charlottesville, Virginia

N.L. Bolen

Immunohematology Reference Laboratory, ITxM Diagnostics, Richmond, VA

G. Meny

Medical Affairs Diagnostic, Grifols Diagnostic Solutions, San Marcos, TX

M. Kalvelage

monica.kalvelage@lifeshare.org

LifeShare Blood Center, Shreveport, Louisiana

G. Ochoa-Garay

Immunohematology Center, Grifols Diagnostic Solutions, San Marcos, TX

DOI: https://doi.org/10.21307/immunohematology-2020-050 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 123 - 128

Published on: Jan 1, 2020

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

blood group genotyping,

sickle cell disease,

Related subjects:

Clinical medicine,

Laboratory medicine

© 2020 C.A. Sheppard, N.L. Bolen, G. Meny, M. Kalvelage, G. Ochoa-Garay, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous article Volume 36 (2020): Issue 4 (December 2020)Next article